Cutera (NASDAQ:CUTR) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR) in a research report report published on Saturday. The brokerage issued a sell rating on the medical device company’s stock.

Cutera Stock Performance

Shares of NASDAQ:CUTR opened at $0.43 on Friday. The stock has a market capitalization of $8.68 million, a price-to-earnings ratio of -0.07 and a beta of 1.32. Cutera has a 1-year low of $0.28 and a 1-year high of $3.00. The company’s fifty day moving average is $0.42 and its two-hundred day moving average is $0.56.

Institutional Trading of Cutera

An institutional investor recently bought a new position in Cutera stock. Sculptor Capital LP acquired a new position in Cutera, Inc. (NASDAQ:CUTR) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 166,000 shares of the medical device company’s stock, valued at approximately $59,000. Sculptor Capital LP owned 0.82% of Cutera as of its most recent SEC filing. 90.70% of the stock is currently owned by institutional investors and hedge funds.

Cutera Company Profile

Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.